Account
Inquiry
We specialize in factory - direct supply, wholesale, customization, and provision of tirzepatide 20mg powder, a high - purity (99.9%) white powder with CAS No. 2023788 - 19 - 2, suitable for research use only (not for personal use). Our tirzepatide 20mg is of pharmacy grade, ensuring reliable quality for scientific investigations related to type 2 diabetes, weight loss mechanisms, and related metabolic studies.
Tirzepatide 20mg (also known as LY3298176) is a dual glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptor agonist. This unique dual - agonist property makes it a valuable research tool for exploring novel therapeutic approaches. In pre - clinical and clinical research models, tirzepatide 20mg has demonstrated potential in regulating glucose metabolism and influencing weight - related pathways, outperforming some single - receptor agonists in certain research - based efficacy assessments.
The molecular formula of tirzepatide 20mg is C₂₂₅H₃₄₈N₄₈O₆₈, with a molecular weight of 4813. Its appearance as a white powder, combined with a 99.9% purity level, ensures minimal impurities that could interfere with research experiments. The packaging of our tirzepatide 20mg is available as 10mg/vial, with 10 vials per box, and we support bulk order customizations to meet different research scale requirements, whether it's small - scale experimental testing or large - scale pre - clinical research projects.
From a research perspective, tirzepatide 20mg’s dual - receptor action (with higher affinity for GIP receptors compared to GLP - 1 receptors) provides a unique model for studying the synergistic effects of GIP and GLP - 1 in metabolic regulation. Research has shown that this dual - agonist can mimic the actions of natural GIP at the GIP receptor, while also activating GLP - 1 receptors, opening up new avenues for understanding complex metabolic pathways in conditions like type 2 diabetes and obesity - related research.
In weight - loss - related research, tirzepatide 20mg has been a focal point in phase 3 clinical trials (for research purposes) investigating its impact on overweight, obese, or weight - related health issue - affected adult populations. For example, in the SURMOUNT - 1 research - oriented trial (modified for research context), different dose levels (including the 20mg range in extended research scenarios) showed varying degrees of weight - loss - related effects, providing valuable data for understanding dose - response relationships in metabolic research.
Our factory - produced tirzepatide 20mg undergoes strict quality control measures to ensure that each batch meets the high standards required for research. We offer wholesale pricing for larger research - focused orders, and our customization service allows researchers to request specific packaging, purity adjustments (within research - compliant ranges), or even custom synthesis - related modifications to align with unique experimental designs. Whether you are conducting basic research on metabolic pathways or exploring potential therapeutic targets, tirzepatide 20mg (for research use) is a reliable choice, backed by our factory’s commitment to quality, wholesale affordability, and customizable solutions to fit your research needs.
